New treatments for rheumatoid arthritis
- 1 January 1999
- journal article
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 106 (4) , 82-92
- https://doi.org/10.3810/pgm.1999.10.1.703
Abstract
PREVIEWNo single therapeutic agent has been found to be universally effective for rheumatoid arthritis, so regimens using combinations of drugs have become the rule. Recently, several new agents with unique mechanisms of action have been introduced and found to produce various degrees of clinical benefit. Among these agents are folate and purine antagonists, alkylating agents, and antipyrimidines. Chimeric (mouse/human) monoclonal antibody to tumor necrosis factor'alpha and human recombinant interleukin-1 receptor antagonist await approval for general use but have undergone considerable study.Keywords
This publication has 17 references indexed in Scilit:
- Therapeutic actions of cyclosporine and anti-tumor necrosis factor ? in collagen-induced arthritis and the effect of combination therapyArthritis & Rheumatism, 1998
- Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: Efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effectsArthritis & Rheumatism, 1998
- Two activities of the immunosuppressive metabolite of leflunomide, A77 1726Biochemical Pharmacology, 1996
- Treatment of Rheumatoid Arthritis with Methotrexate Alone, Sulfasalazine and Hydroxychloroquine, or a Combination of All Three MedicationsNew England Journal of Medicine, 1996
- Inhibition of the production and effects of interleukins‐1 and tumor necrosis factor α in rheumatoid arthritisArthritis & Rheumatism, 1995
- A randomized, double‐blind, 24‐week controlled study of low‐dose cyclosporine versus chloroquine for early rheumatoid arthritisArthritis & Rheumatism, 1994
- Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor αArthritis & Rheumatism, 1993
- Localization of tumor necrosis factor receptors in the synovial tissue and cartilage‐pannus junction in patients with rheumatoid arthritis. Implications for local actions of tumor necrosis factor αArthritis & Rheumatism, 1992
- Rheumatoid ArthritisNew England Journal of Medicine, 1990
- Cyclosporin treatment for rheumatoid arthritis: a placebo controlled, double blind, multicentre study.Annals of the Rheumatic Diseases, 1986